Publications in collaboration with researchers from University of California, San Diego (2)

2022

  1. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 128-140

2016

  1. Ustekinumab as induction and maintenance therapy for Crohn's disease

    New England Journal of Medicine, Vol. 375, Núm. 20, pp. 1946-1960